the term "validating the efficacy of kevetrin" does not appear in the PR leo sent out about the u of bologna requesting kevetrin for a trial with cytarabine for AML. this following a mouse study with cytarabine and kevetrin. the trial is sponsored by two groups in europe.
it is i who infer from this that the u of bologna has been privy to the results from dana farber which had to show efficacy or why else ask for our drug for a trial?
News 
Market Data 
Discover 
AI
